Breaking news
Rubrik pops 20% in NYSE debut soon after pricing IPO earlier mentioned selection
Bipul Sinha, CEO, Chairman & Co-Founder of Rubrik Inc., the Microsoft backed cybersecurity application startup, rings the opening bell throughout his company’s IPO at the New York Stock Trade (NYSE) in New York Town, U.S., April 25, 2024. Brendan Mcdermid | Reuters Info management software package maker Rubrik jumped in its New York Stock Trade debut on […]
Read More
Stripe co-founder claims large curiosity prices flushed out Silicon Valley’s ‘wackiest’ concepts
John Collison, president and co-founder of Stripe. Christophe Morin | IP3 | Getty Visuals Growing fascination costs crushed technologies valuations and experienced a chilling influence on Silicon Valley. Stripe’s co-founder states it was desired. “Broadly talking, the effects of higher premiums have been quite excellent,” John Collison, president of the on the net payments corporation, […]
Read More
GDP expansion slowed to a 1.6% level in the to start with quarter, nicely down below expectations
U.S. financial progress was significantly weaker than anticipated to start the yr, and rates rose at a a lot quicker tempo, the Commerce Department noted Thursday. Gross domestic product, a wide evaluate of merchandise and services manufactured in the January-by way of-March interval, amplified at a 1.6% annualized tempo when adjusted for seasonality and inflation, […]
Read More
Bristol Myers Squibb beats on revenue, launches $1.5 billion cost cuts as it posts quarterly loss
The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, on Dec. 27, 2023. Adam Glanzman | Bloomberg | Getty Images Bristol Myers Squibb on Thursday reported first-quarter revenue that topped expectations as its blockbuster blood thinner Eliquis and several new drugs posted sales growth. But the pharmaceutical company swung to […]
Read More
Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales
Exterior view of the entrance to Merck headquarters on February 05, 2024 in Rahway, New Jersey. Spencer Platt | Getty Images Merck on Thursday reported first-quarter revenue and adjusted earnings that topped expectations as it posted strong sales of its blockbuster cancer drug Keytruda and vaccine products. The pharmaceutical giant also raised and narrowed its […]
Read More
Ukraine war stay updates: Russian strikes strike Ukrainian significant infrastructure British isles finance minister visits Kyiv
U.K. Finance Minister Jeremy Hunt visits Kyiv British Finance Minister Jeremy Hunt met with Ukrainian President Volodymyr Zelenskyy in Kyiv, the Ukrainian chief mentioned Thursday. “I welcomed the UK’s Chancellor of the Exchequer, @Jeremy_Hunt, and thanked him for the UK’s greatest protection support package, value 50 % a billion kilos,” Zelenskyy mentioned on the X […]
Read More
Walgreens to help bring cell and gene therapies to patients as it expands specialty pharmacy services
A person rides past a Walgreens truck, owned by the Walgreens Boots Alliance, in Manhattan, New York City, on Nov. 26, 2021. Andrew Kelly | Reuters Walgreens on Thursday said it will start to work directly with drugmakers to bring cell and gene therapies to U.S. patients as part of a broader expansion of its specialty […]
Read More
Stocks making the most important moves midday: Tesla, Hilton, Boeing, Mattel and more
Examine out the companies building headlines in midday buying and selling: Boeing — The aerospace big fell 1.5% even after noting that it burned as a result of $3.9 billion in money in the first quarter. The funds melt away was lessen than what analysts had feared. Boeing also posted an adjusted decline of $1.13 […]
Read More
Biogen tops profit estimates as cost cuts take hold, Alzheimer’s drug Leqembi launch picks up
A test tube is seen in front of displayed Biogen logo in this illustration taken on, December 1, 2021. Dado Ruvic | Reuters Biogen on Wednesday reported first-quarter profit that topped estimates as the company’s cost-cutting efforts took hold and sales of its closely watched Alzheimer’s drug, Leqembi, came in higher than expected. Biogen and […]
Read More
More than 3 million Medicare patients could be eligible for coverage of Wegovy to reduce heart disease risks, study says
More than 3 million people with Medicare could be eligible for coverage of Wegovy now that the blockbuster weight loss drug is also approved in the U.S. for heart health, according to an analysis released Wednesday by health policy research organization KFF. But some eligible beneficiaries could still face out-of-pocket costs for the highly popular […]
Read More